Abstract
A series of protease activated receptor 2 activating peptide (PAR2-AP) derivatives (1–15) were designed and synthesized. The obtained compounds were tested on a panel of human kallikreins (hKLK1, hKLK2, hKLK5, hKLK6, and hKLK7) and were found completely inactive toward hKLK1, hKLK2, and hKLK7. Aiming to investigate the mode of interaction between the most interesting compounds and the selected hKLKs, docking studies were performed. The described compounds distinguish the different human tissue kallikreins with compounds 1 and 5 as the best hKLK5 and hKLK6 inhibitors, respectively.
一系列蛋白酶激活受体2激活肽(PAR2-AP)衍生物(1-15)被设计并合成。获得的化合物在一系列人类激肽酶(hKLK1、hKLK2、hKLK5、hKLK6和hKLK7)上进行了测试,发现对hKLK1、hKLK2和hKLK7完全无活性。为了研究最有趣的化合物与选择的hKLKs之间的相互作用方式,进行了对接研究。所描述的化合物区分了不同的人类组织激肽酶,其中化合物1和5分别是最好的hKLK5和hKLK6抑制剂。